Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2011

Conditions

Advanced Solid Tumors

Interventions

DRUG

Lipotecan

Lipotecan IV day 1, 8, 15

Trial Locations (4)

Montefiore Medical Center, The Bronx

Medical College of Georgia, Augusta

Bidmc, Dfci, Mgh, Boston

National Taiwan University Hospital, Taipei